Sign in
Explore the registryTrack Pembrolizumab's trials

Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)

Pembrolizumab (neoadjuvant)OngoingRecruitingPhase 2Open NCT06788912 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…